Trade Mark Journal No.2025/021 23 May 2025

WO0000001853002 (1,5)

Office of origin: United States of America

Date of International Registration:1 April 2025
Date of designation in the UK: 1 April 2025
Image for mark 1853002 MABETULENE

International priority date claimed: 7 October 2024 (United States of America) (98788289)
Class 1
Active chemical ingredients for use in the manufacture of anti-cancer drugs.
Class 5
Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer.

Gerosynth Laboratories Inc.

Representative: Greg Gronholm Gronholm Patent Services, 96 Craig Street, Suite 112-318, East Ellijay GA 30540, UNITED STATES OF AMERICA